Complications of beta-thalassemia major in North America.
Melody J Cunningham, Eric A Macklin, Ellis J Neufeld...
https://pubmed.ncbi.nlm.nih.gov/14988152Completed
Led by Carelon Research · Updated on 2014-03-04
1000
Participants Needed
5
Research Sites
N/A
Total Duration
C
Carelon Research
Lead Sponsor
N
National Heart, Lung, and Blood Institute (NHLBI)
Collaborating Sponsor
The purpose of the TCRN is to accelerate research in the management of thalassemia, standardize existing treatments, and evaluate new ones in a network of clinical centers in North America. The emphasis will be on clinical trials that help identify optimal therapy. Therapeutic trials may involve investigational drugs, drugs already approved but not currently used, and drugs currently used.
CONDITIONS
Thalassemia (Cooley's Anemia) Clinical Research Network (TCRN)
You may qualify if you...
Please refer to specific studies for eligibility criteria.
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
Total: 5 locations
1
Children's Hospital Oakland
Oakland, California, United States, 94609
Status Unknown
2
Children's Hospital
Boston, Massachusetts, United States, 02115
Status Unknown
3
Weill Medical College of Cornell University
New York, New York, United States, 10021
Status Unknown
4
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, United States, 19104
Status Unknown
5
Toronto General Hospital
Toronto, Ontario, Canada, M5G 2C4
Status Unknown
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Melody J Cunningham, Eric A Macklin, Ellis J Neufeld...
https://pubmed.ncbi.nlm.nih.gov/14988152